CF vs RIGL · P/E 12, rev $5.94B vs P/E 9.1, rev $179.3M
CF Industries Holdings Inc (CF) versus Rigel Pharmaceuticals Inc (RIGL) — a side-by-side from cached financials, not a winner call.
CF Industries Holdings Inc (CF) is a agricultural inputs company listed on US.
Rigel Pharmaceuticals Inc (RIGL) is a biotechnology company listed on US.
Latest reported CF revenue for 2024-12-31 was $5.94B. Net income was $1.48B. Revenue was down 10.5% from 2023-12-31 to 2024-12-31. CF currently screens at market cap $14.98B and trailing P/E 12.2.
Latest reported RIGL revenue for 2024-12-31 was $179.3M. Net income was $17.5M. Revenue was up 53.4% from 2023-12-31 to 2024-12-31. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
CF currently screens at market cap $14.98B and trailing P/E 12.2. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
Not investment advice. Open the CF and RIGL stock pages for the full models.
Not investment advice.